Drug Stocks In News (CELG, BJGP, PFE)
Celgene Corporation (NASDAQ:CELG) went up 3.03% to $61.20. The company said on Thursday its third-quarter earnings rose 30 percent, topping expectations on higher sales of its multiple myeloma drug Revlimid. Net profit rose to $281.2 million, or 60 cents a share, from $217 million, or 46 cents a share a year ago. The company said [...]
Drug Stocks in Focus (JNJ, CSCX, PFE, LLY)
Johnson & Johnson (NYSE:JNJ) dropped 1.21% to $63.09. The company reported a higher third-quarter profit, although sales came in slightly below those of the same quarter in 2009. J&J said it earned $3.42 billion, or $1.23 a share, compared with $3.35 billion, $1.20 a share, for the prior year’s quarter. A poll of analysts by [...]
Hot US Stocks Alert (Sprint, DELL, PFE)
Sprint Nextel Corporation (NYSE:S) added 2.47% to $4.57 on about 23.68 million share. Sprint Nextel Corporation (Sprint) is a holding company that offers a range of wireless and wireline communications products and services for individual consumers, businesses, government subscribers and resellers. Dell Inc. (NASDAQ:DELL) slid 0.20% to $13.70 on about 15.23 million shares. Dell Inc. [...]
Drug Stocks Closed Higher (BSX, PFE, GILD, MYL)
Boston Scientific Corporation (NYSE:BSX) surged 2.63% to $6.24 on over 17.50 million shares. Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties, including cardiac rhythm management, electrophysiology, interventional cardiology, peripheral interventions, neurovascular, endoscopy, urology, women’s health and neuromodulation. Over the past 52-week, [...]
Large Cap Stocks Ended Lower (GE, Citigroup Inc., PFE, INTC)
General Electric Company (NYSE:GE) fell 1.38% to $16.43 on over 40.57 million shares. Vivendi announced that in accordance with the agreement between Vivendi and GE covering Vivendi`s full exit from NBC Universal, Vivendi has concluded the sale of 7.66% of NBC Universal to GE for $2 billion. The remainder of Vivendi`s stake, or 12.34%, will [...]